Every 8-K that Innovative Eyewear, Inc. (LUCY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow LUCY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LUCY filings page.
Innovative Eyewear (LUCY) reported preliminary, unaudited net sales for the third quarter ended September 30, 2026; management described them as the highest quarterly net sales in company history. The estimates remain subject to completion of quarter-end close procedures and review of interim financial statements, and actual results may differ materially.
During the quarter, the company opened three wholesale and international channels: a major U.S. big-box retailer, FYihealth Group in Canada, and Directed Electronics in Australia and New Zealand. The company plans to launch Lucyd Aero for holiday 2026 and expects to report full third-quarter results in mid-November 2026.
Innovative Eyewear, Inc. entered an inducement agreement with a warrant holder to immediately exercise 2,200,544 existing warrants at a reduced price of $1.35 per share, generating approximately $3.0 million in gross proceeds. In return, the company is issuing new unregistered Series J warrants to purchase up to 6,601,632 shares of common stock at an exercise price of $1.10 per share, exercisable immediately for 24 months after a future resale registration becomes effective. The company plans to use net proceeds for working capital and general corporate purposes, has engaged H.C. Wainwright & Co. as exclusive placement agent with cash fees and expense reimbursements, and will also issue placement agent warrants to buy 165,041 shares at $1.6875 per share.
Innovative Eyewear, Inc. filed a current report to disclose that it issued a press release with preliminary financial results and operational highlights for its 2025 fiscal year. The company states that the press release, dated January 7, 2026, is included as Exhibit 99.1 to this report and is furnished under Items 2.02 and 7.01 of the Exchange Act.
The company clarifies that this information is being furnished rather than filed, meaning it is not subject to certain liability provisions of the Exchange Act and will only be incorporated into other securities filings if specifically referenced.
Innovative Eyewear (LUCY) announced executive title changes. Konrad Dabrowski resigned as Co‑Chief Financial Officer and became Chief AI and Growth Officer. Oswald Gayle, previously Co‑Chief Financial Officer, is now Chief Financial Officer and will serve as the company’s principal financial officer.
The Board of Directors approved these changes effective November 1, 2025. The company stated there were no compensation changes for Mr. Dabrowski or Mr. Gayle in connection with the new roles.
Innovative Eyewear, Inc. (LUCY) reported results of its 2025 annual meeting of stockholders. Of 3,574,602 shares entitled to vote, 1,793,176 shares were present or represented by proxy. Stockholders elected Harrison Gross, Kristen McLaughlin, Louis Castro, and Olivia Bartlett as directors. They ratified Cherry Bekaert LLP as independent auditor for the year ending December 31, 2025 (For 1,559,255; Against 164,120; Abstain 69,801).
Stockholders approved a name change from Innovative Eyewear, Inc. to Lucyd, Inc. (For 1,533,867; Against 188,709; Abstain 70,600) and ratified a one-year extension of the Company’s rights plan (For 809,239; Against 17,908; Abstain 56,896; Broker Non-Votes 909,133). A proposal to reinstate the voting rights of certain control shares was not approved (For 206,055; Against 552,591; Abstain 103,858; Broker Non-Votes 930,594).
Innovative Eyewear, Inc. adjourned its annual meeting after a quorum of common stockholders was not present in person or by proxy to transact business.
The meeting was approved for adjournment by all shares represented and entitled to vote on the adjournment and will reconvene on October 24, 2025 at 10:00 a.m. ET on a virtual basis. The reconvened meeting will consider the proposals described in the notice sent to stockholders of record as of June 30, 2025.